buserelin has been researched along with medroxyprogesterone in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (50.00) | 18.7374 |
| 1990's | 10 (45.45) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (4.55) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diedrich, K; Naether, O | 1 |
| Beard, RW; Gangar, KF; Reid, BA | 1 |
| Baird, DT; Lumsden, MA; West, CP | 1 |
| Baird, DT; Hillier, H; Lumsden, MA; Sweeting, V; West, CP | 1 |
| Broux, R; Corhay, JL; Limet, R; Radermecker, M | 1 |
| Yokoya, S | 1 |
| Blanchet, P; Friede, J; Lemay, A; Maheux, R; Pratt, X | 1 |
| Borlée, G; Broux, R; Bury, T; Corhay, JL; Gaspard, U; Gustin, M; Limet, R; Noël, F; Radermecker, MA; Saint-Remy, P | 1 |
| Kuhl, H; Pietzsch, V | 1 |
| Abbondante, G; Aleandri, V; Benagiano, G; Elkind-Hirsch, K; Morini, A; Piccinno, F; Primiero, FM | 1 |
| Bargetzi, MJ; Birkhaeuser, MH; Meyer, UA | 1 |
| Dodin Dewailly, S; Lemay, A | 1 |
| Lemay, A | 1 |
| Azaretzky, M; Boquete, HR; Cagide, AL; Damilano, S; Fideleff, HL; Levalle, O | 1 |
| Bettendorf, G; Bispink, L; Braendle, W; Lichtenberg, V; Lindner, C | 1 |
| Terakawa, N | 1 |
| Faure, N; Lemay, A | 1 |
| Bastide, A; Faure, N; Lemay, A | 1 |
| Faure, N; Jean, C; Lemay, A | 1 |
| Debruyne, FM | 1 |
| Faure, N; Fazekas, AT; Labrie, F; Lemay, A | 1 |
| Corti, M; de Nava, G; Demmers, KJ; Juengel, J; Martinez, MF; Rodriguez Sabarrós, M; Smaill, B; Tutt, D | 1 |
1 review(s) available for buserelin and medroxyprogesterone
| Article | Year |
|---|---|
Goserelin (Zoladex) in the treatment of fibroids.
Topics: Buserelin; Combined Modality Therapy; Drug Therapy, Combination; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Receptors, Estradiol; Tamoxifen; Uterine Neoplasms | 1992 |
4 trial(s) available for buserelin and medroxyprogesterone
| Article | Year |
|---|---|
Potential role for medroxyprogesterone acetate as an adjunct to goserelin (Zoladex) in the medical management of uterine fibroids.
Topics: Adult; Buserelin; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Uterine Neoplasms | 1992 |
Sequential Gn-RH superagonist and medroxyprogesterone acetate treatment of uterine leiomyomata.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buserelin; Delayed-Action Preparations; Female; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Time Factors; Ultrasonography; Uterine Neoplasms | 1990 |
Results of a Dutch trial with the LHRH agonist buserelin in patients with metastatic prostatic cancer and results of EORTC studies in prostatic cancer.
Topics: Aged; Buserelin; Clinical Trials as Topic; Combined Modality Therapy; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Humans; Lymphatic Metastasis; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Netherlands; Orchiectomy; Prostatic Neoplasms; Remission Induction; Time Factors | 1988 |
Intravaginal progesterone devices in synchronization protocols for artificial insemination in beef heifers.
Topics: Administration, Intravaginal; Animals; Buserelin; Cattle; Estradiol; Estrus Synchronization; Female; Insemination, Artificial; Medroxyprogesterone; Oligopeptides; Pregnancy; Progesterone | 2012 |
17 other study(ies) available for buserelin and medroxyprogesterone
| Article | Year |
|---|---|
[Intrauterine pregnancy with uterine myoma after downregulation with GnRH analogs].
Topics: Adult; Antineoplastic Agents; Buserelin; Delayed-Action Preparations; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Complications, Neoplastic; Receptors, LHRH; Uterine Neoplasms | 1992 |
Severe endometriosis treated with gonadotrophin releasing hormone agonist and continuous combined hormone replacement therapy.
Topics: Adult; Buserelin; Drug Therapy, Combination; Endometriosis; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Goserelin; Humans; Medroxyprogesterone; Pelvic Neoplasms | 1992 |
Failure of buserelin-induced medical castration to control pulmonary lymphangiomyomatosis in two patients.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Drug Evaluation; Female; Humans; Lung Neoplasms; Lymphangiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovary; Pneumothorax; Recurrence; Tamoxifen | 1992 |
[Etiology and therapy of virilism and precocious puberty].
Topics: Adrenal Hyperplasia, Congenital; Buserelin; Child; Cyproterone; Cyproterone Acetate; Dexamethasone; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Puberty, Precocious; Virilism | 1992 |
Maintained reduction of uterine leiomyoma following addition of hormonal replacement therapy to a monthly luteinizing hormone-releasing hormone agonist implant: a pilot study.
Topics: Adult; Antineoplastic Agents; Bone Density; Buserelin; Cholesterol; Contraceptive Agents, Female; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Goserelin; Humans; Leiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Pilot Projects; Triglycerides; Uterine Neoplasms | 1991 |
[Apropos of 2 cases of lymphangiomyomatosis treated with LH-RH agonists].
Topics: Adult; Antineoplastic Agents; Buserelin; Female; Humans; Lung Neoplasms; Lymphangiomyoma; Medroxyprogesterone; Medroxyprogesterone Acetate; Tomography, X-Ray Computed | 1991 |
[Contraception with cyclic administration of buserelin and gestagens: increase in testosterone and free testosterone serum concentration].
Topics: Administration, Intranasal; Adult; Buserelin; Contraceptives, Oral, Combined; Female; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norethindrone Acetate; Protein Binding; Testosterone | 1991 |
Premenstrual exacerbations in hepatic porphyria: prevention by intermittent administration of an LH-RH agonist in combination with a gestagen.
Topics: Acute Disease; Adult; Buserelin; Drug Therapy, Combination; Female; Humans; Liver Diseases; Medroxyprogesterone; Menstruation; Porphyrias | 1989 |
Long-term use of the low dose LHRH analogue combined with monthly medroxy-progesterone administration.
Topics: Adult; Buserelin; Drug Therapy, Combination; Dysmenorrhea; Endometriosis; Female; Humans; Medroxyprogesterone; Menorrhagia | 1989 |
Intranasal LHRH agonist combined periodically with a progestogen for contraception.
Topics: Administration, Intranasal; Buserelin; Contraceptive Agents, Female; Drug Evaluation; Endometriosis; Female; Humans; Medroxyprogesterone; Menstruation Disturbances | 1989 |
[Subcutaneous and intranasal use of a LH-RH analog in the treatment of girls with central precocious puberty].
Topics: Administration, Intranasal; Buserelin; Child; Child, Preschool; Female; Follicle Stimulating Hormone; Humans; Infant; Injections, Subcutaneous; Luteinizing Hormone; Medroxyprogesterone; Puberty, Precocious; Sexual Maturation | 1989 |
[GnRH agonist/hMG stimulation in gamete intrafallopian transfer (GIFT)].
Topics: Administration, Intranasal; Adult; Buserelin; Combined Modality Therapy; Delayed-Action Preparations; Drug Administration Schedule; Female; Follow-Up Studies; Gamete Intrafallopian Transfer; Gonadotropin-Releasing Hormone; Humans; Infertility, Female; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Pregnancy; Pregnancy Outcome; Triptorelin Pamoate | 1989 |
[Studies on endocrine therapy of endometriosis].
Topics: Animals; Buserelin; Danazol; Drug Therapy, Combination; Endometriosis; Estradiol; Female; Gestrinone; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovary; Pregnadienes; Rats; Rats, Inbred Strains | 1989 |
Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
Topics: Administration, Intranasal; Adult; Buserelin; Contraceptives, Oral, Combined; Drug Administration Schedule; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstrual Cycle; Progesterone | 1986 |
Ovarian sonographic findings during intermittent intranasal luteinizing hormone-releasing hormone agonist sequentially combined with an oral progestogen as antiovulatory contraceptive approach.
Topics: Administration, Intranasal; Adult; Buserelin; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovary; Ovulation; Ultrasonography | 1987 |
Endometrial histology during intermittent intranasal luteinizing hormone-releasing hormone (LH-RH) agonist sequentially combined with an oral progestogen as an antiovulatory contraceptive approach.
Topics: Adult; Biopsy; Buserelin; Contraceptive Agents, Female; Endometrium; Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstrual Cycle; Progesterone | 1987 |
Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
Topics: Administration, Intranasal; Adult; Buserelin; Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Ovary; Ovulation; Progesterone; Prolactin; Testosterone; Ultrasonics | 1985 |